NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma

Daria A. Gaykalova, Judith B. Manola, Hiroyuki Ozawa, Veronika Zizkova, Kathryn Morton, Justin A. Bishop, Rajni Sharma, Chi Zhang, Christina Michailidi, Michael Considine, Marietta Tan, Elana J. Fertig, Patrick T. Hennessey, Julie Ahn, Wayne M. Koch, William H. Westra, Zubair Khan, Christine H. Chung, Michael F. Ochs, Joseph A. Califano

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Using high-throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by inferential analysis of target gene expression, correcting for the effects of DNA methylation and copy number. Using this discovery pipeline, we determined that human papillomavirus-related (HPV+) and HPV- HNSCC differed significantly based on the activity levels of key TFs including AP1, STATs, NF-κB and p53. Immunohistochemical analysis confirmed that HPV- HNSCC is characterized by co-activated STAT3 and NF-κB pathways and functional studies demonstrate that this phenotype can be effectively targeted with combined anti-NF-κB and anti-STAT therapies. These discoveries correlate strongly with previous findings connecting STATs, NF-κB and AP1 in HNSCC. We identified five top-scoring pair biomarkers from STATs, NF-κB and AP1 pathways that distinguish HPV+ from HPV- HNSCC based on TF activity and validated these biomarkers on TCGA and on independent validation cohorts. We conclude that a novel approach to TF pathway analysis can provide insight into therapeutic targeting of patient subgroup for heterogeneous disease such as HNSCC. What's new? Changes in transcription factor (TF) expression contribute to genetic and epigenetic abnormalities in cancer. In order to capitalize on those changes and advance diagnostic and therapeutic strategies for cancer, researchers must first find a way to detect and quantify changes in TF activity. Here, TF activity was estimated globally in primary head and neck squamous cell carcinoma (HNSCC) using a novel inferential approach that accounted for gene silencing and loss of heterozygosity and homozygosity. Top-scoring pair biomarkers were identified and linked to human papillomavirus (HPV) status, enabling HPV+ and HPV- HNSCC to be distinguished based on TF activity.

Original languageEnglish
Pages (from-to)1879-1889
Number of pages11
JournalInternational Journal of Cancer
Volume137
Issue number8
DOIs
Publication statusPublished - 2015 Oct 15
Externally publishedYes

Fingerprint

Transcription Factors
Biomarkers
Carcinoma, squamous cell of head and neck
Loss of Heterozygosity
Gene Silencing
DNA Methylation
Epigenomics
Statistical Factor Analysis
Neoplasms
Therapeutics
Research Personnel
Databases
Phenotype
Gene Expression

Keywords

  • HNSCC
  • HPV
  • NF-κB
  • STAT3
  • transcription factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma. / Gaykalova, Daria A.; Manola, Judith B.; Ozawa, Hiroyuki; Zizkova, Veronika; Morton, Kathryn; Bishop, Justin A.; Sharma, Rajni; Zhang, Chi; Michailidi, Christina; Considine, Michael; Tan, Marietta; Fertig, Elana J.; Hennessey, Patrick T.; Ahn, Julie; Koch, Wayne M.; Westra, William H.; Khan, Zubair; Chung, Christine H.; Ochs, Michael F.; Califano, Joseph A.

In: International Journal of Cancer, Vol. 137, No. 8, 15.10.2015, p. 1879-1889.

Research output: Contribution to journalArticle

Gaykalova, DA, Manola, JB, Ozawa, H, Zizkova, V, Morton, K, Bishop, JA, Sharma, R, Zhang, C, Michailidi, C, Considine, M, Tan, M, Fertig, EJ, Hennessey, PT, Ahn, J, Koch, WM, Westra, WH, Khan, Z, Chung, CH, Ochs, MF & Califano, JA 2015, 'NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma', International Journal of Cancer, vol. 137, no. 8, pp. 1879-1889. https://doi.org/10.1002/ijc.29558
Gaykalova, Daria A. ; Manola, Judith B. ; Ozawa, Hiroyuki ; Zizkova, Veronika ; Morton, Kathryn ; Bishop, Justin A. ; Sharma, Rajni ; Zhang, Chi ; Michailidi, Christina ; Considine, Michael ; Tan, Marietta ; Fertig, Elana J. ; Hennessey, Patrick T. ; Ahn, Julie ; Koch, Wayne M. ; Westra, William H. ; Khan, Zubair ; Chung, Christine H. ; Ochs, Michael F. ; Califano, Joseph A. / NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma. In: International Journal of Cancer. 2015 ; Vol. 137, No. 8. pp. 1879-1889.
@article{16830c3ea0ae45a6baea8f63326d0067,
title = "NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma",
abstract = "Using high-throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by inferential analysis of target gene expression, correcting for the effects of DNA methylation and copy number. Using this discovery pipeline, we determined that human papillomavirus-related (HPV+) and HPV- HNSCC differed significantly based on the activity levels of key TFs including AP1, STATs, NF-κB and p53. Immunohistochemical analysis confirmed that HPV- HNSCC is characterized by co-activated STAT3 and NF-κB pathways and functional studies demonstrate that this phenotype can be effectively targeted with combined anti-NF-κB and anti-STAT therapies. These discoveries correlate strongly with previous findings connecting STATs, NF-κB and AP1 in HNSCC. We identified five top-scoring pair biomarkers from STATs, NF-κB and AP1 pathways that distinguish HPV+ from HPV- HNSCC based on TF activity and validated these biomarkers on TCGA and on independent validation cohorts. We conclude that a novel approach to TF pathway analysis can provide insight into therapeutic targeting of patient subgroup for heterogeneous disease such as HNSCC. What's new? Changes in transcription factor (TF) expression contribute to genetic and epigenetic abnormalities in cancer. In order to capitalize on those changes and advance diagnostic and therapeutic strategies for cancer, researchers must first find a way to detect and quantify changes in TF activity. Here, TF activity was estimated globally in primary head and neck squamous cell carcinoma (HNSCC) using a novel inferential approach that accounted for gene silencing and loss of heterozygosity and homozygosity. Top-scoring pair biomarkers were identified and linked to human papillomavirus (HPV) status, enabling HPV+ and HPV- HNSCC to be distinguished based on TF activity.",
keywords = "HNSCC, HPV, NF-κB, STAT3, transcription factor",
author = "Gaykalova, {Daria A.} and Manola, {Judith B.} and Hiroyuki Ozawa and Veronika Zizkova and Kathryn Morton and Bishop, {Justin A.} and Rajni Sharma and Chi Zhang and Christina Michailidi and Michael Considine and Marietta Tan and Fertig, {Elana J.} and Hennessey, {Patrick T.} and Julie Ahn and Koch, {Wayne M.} and Westra, {William H.} and Zubair Khan and Chung, {Christine H.} and Ochs, {Michael F.} and Califano, {Joseph A.}",
year = "2015",
month = "10",
day = "15",
doi = "10.1002/ijc.29558",
language = "English",
volume = "137",
pages = "1879--1889",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma

AU - Gaykalova, Daria A.

AU - Manola, Judith B.

AU - Ozawa, Hiroyuki

AU - Zizkova, Veronika

AU - Morton, Kathryn

AU - Bishop, Justin A.

AU - Sharma, Rajni

AU - Zhang, Chi

AU - Michailidi, Christina

AU - Considine, Michael

AU - Tan, Marietta

AU - Fertig, Elana J.

AU - Hennessey, Patrick T.

AU - Ahn, Julie

AU - Koch, Wayne M.

AU - Westra, William H.

AU - Khan, Zubair

AU - Chung, Christine H.

AU - Ochs, Michael F.

AU - Califano, Joseph A.

PY - 2015/10/15

Y1 - 2015/10/15

N2 - Using high-throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by inferential analysis of target gene expression, correcting for the effects of DNA methylation and copy number. Using this discovery pipeline, we determined that human papillomavirus-related (HPV+) and HPV- HNSCC differed significantly based on the activity levels of key TFs including AP1, STATs, NF-κB and p53. Immunohistochemical analysis confirmed that HPV- HNSCC is characterized by co-activated STAT3 and NF-κB pathways and functional studies demonstrate that this phenotype can be effectively targeted with combined anti-NF-κB and anti-STAT therapies. These discoveries correlate strongly with previous findings connecting STATs, NF-κB and AP1 in HNSCC. We identified five top-scoring pair biomarkers from STATs, NF-κB and AP1 pathways that distinguish HPV+ from HPV- HNSCC based on TF activity and validated these biomarkers on TCGA and on independent validation cohorts. We conclude that a novel approach to TF pathway analysis can provide insight into therapeutic targeting of patient subgroup for heterogeneous disease such as HNSCC. What's new? Changes in transcription factor (TF) expression contribute to genetic and epigenetic abnormalities in cancer. In order to capitalize on those changes and advance diagnostic and therapeutic strategies for cancer, researchers must first find a way to detect and quantify changes in TF activity. Here, TF activity was estimated globally in primary head and neck squamous cell carcinoma (HNSCC) using a novel inferential approach that accounted for gene silencing and loss of heterozygosity and homozygosity. Top-scoring pair biomarkers were identified and linked to human papillomavirus (HPV) status, enabling HPV+ and HPV- HNSCC to be distinguished based on TF activity.

AB - Using high-throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by inferential analysis of target gene expression, correcting for the effects of DNA methylation and copy number. Using this discovery pipeline, we determined that human papillomavirus-related (HPV+) and HPV- HNSCC differed significantly based on the activity levels of key TFs including AP1, STATs, NF-κB and p53. Immunohistochemical analysis confirmed that HPV- HNSCC is characterized by co-activated STAT3 and NF-κB pathways and functional studies demonstrate that this phenotype can be effectively targeted with combined anti-NF-κB and anti-STAT therapies. These discoveries correlate strongly with previous findings connecting STATs, NF-κB and AP1 in HNSCC. We identified five top-scoring pair biomarkers from STATs, NF-κB and AP1 pathways that distinguish HPV+ from HPV- HNSCC based on TF activity and validated these biomarkers on TCGA and on independent validation cohorts. We conclude that a novel approach to TF pathway analysis can provide insight into therapeutic targeting of patient subgroup for heterogeneous disease such as HNSCC. What's new? Changes in transcription factor (TF) expression contribute to genetic and epigenetic abnormalities in cancer. In order to capitalize on those changes and advance diagnostic and therapeutic strategies for cancer, researchers must first find a way to detect and quantify changes in TF activity. Here, TF activity was estimated globally in primary head and neck squamous cell carcinoma (HNSCC) using a novel inferential approach that accounted for gene silencing and loss of heterozygosity and homozygosity. Top-scoring pair biomarkers were identified and linked to human papillomavirus (HPV) status, enabling HPV+ and HPV- HNSCC to be distinguished based on TF activity.

KW - HNSCC

KW - HPV

KW - NF-κB

KW - STAT3

KW - transcription factor

UR - http://www.scopus.com/inward/record.url?scp=84938951703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938951703&partnerID=8YFLogxK

U2 - 10.1002/ijc.29558

DO - 10.1002/ijc.29558

M3 - Article

C2 - 25857630

AN - SCOPUS:84938951703

VL - 137

SP - 1879

EP - 1889

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -